Medicrea International SA Sustainability Profile
Medicrea International SA, headquartered in France, is a pioneering company in the field of spinal surgery and medical technology. Founded in 2001, Medicrea has established itself as a leader in the development of innovative spinal implants and surgical solutions, focusing on personalised patient care. The company operates primarily in Europe and North America, offering a range of core products, including advanced spinal instrumentation and customised surgical planning software. What sets Medicrea apart is its commitment to utilising artificial intelligence and data analytics to enhance surgical outcomes and improve patient recovery times. With a strong market position, Medicrea has achieved significant milestones, including numerous patents and collaborations with leading healthcare institutions, solidifying its reputation as a trusted partner in the orthopaedic and neurosurgical fields.
DitchCarbon Score
How does Medicrea International SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medicrea International SA's score of 53 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medicrea International SA, headquartered in France, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Medtronic plc, which influences its climate commitments and reporting practices. As part of its corporate family relationship with Medtronic plc, Medicrea may align with the sustainability initiatives and targets set by its parent company. Medtronic has established various climate commitments, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which aim to reduce greenhouse gas emissions across its operations. While specific reduction targets for Medicrea are not detailed, the overarching goals from Medtronic suggest a commitment to improving environmental performance and reducing carbon footprints. This includes initiatives that may impact Scope 1, 2, and 3 emissions, although specific figures for Medicrea are not available. In summary, while Medicrea International SA does not provide direct emissions data or specific reduction targets, it is positioned within a corporate structure that prioritises climate action and sustainability through its relationship with Medtronic plc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | - |
How Carbon Intensive is Medicrea International SA's Industry?
How Carbon Intensive is Medicrea International SA's Location?
Medicrea International SA's Scope 3 Categories Breakdown
Medicrea International SA's Scope 3 emissions, which increased by 48% last year and increased by approximately 48% since 2021, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 55% of total emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the largest emissions source at 47% of Scope 3 emissions.
Top Scope 3 Categories
Medicrea International SA's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medicrea International SA has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
